Hims & Hers Health (HIMS) Surges 10.6% – What’s Fueling This Breakout Move?

Summary
• HIMS jumps 10.6% to $20.77, marking a dramatic intraday rally.
• Trading volume surges to 27.5 million shares, or 13.3% of float.
• Volatility in options chain spikes, with leverage ratios reaching as high as 10.34%.
• The stock breaks above the 30-day moving average and approaches key support/resistance levels.

HIMS is experiencing a sharp intraday reversal from a long-term bearish pattern, sparking urgent interest from traders. With a 10.6% move and rising volatility, the question now is: is this breakout sustainable or a short-lived surge?

Bullish Breakout Amid Elevated Volatility and Gamma Squeeze
HIMS has broken out sharply from a long-term bearish trend, with the stock now trading above its 30-day moving average of $19.46 for the first time in weeks. The rally coincides with a spike in options volume—particularly in low-strike calls—suggesting a gamma squeeze is unfolding. Call options with strike prices from $16 to $19.5 are seeing unusually high turnover and leverage ratios, indicating aggressive long positions are being established ahead of the April 10 expiration. The RSI at 34.08 remains in oversold territory, suggesting potential for further upward momentum as traders rotate into more bullish positioning.

Healthcare Equipment Sector Quiet as HIMS Defies the Trend
While HIMS soars on volatile momentum, the broader Healthcare Equipment sector remains relatively muted. Medtronic (MDT), the sector leader, is up a modest 0.73% intraday, pointing to a divergence in market sentiment between traditional medtech giants and digital health disruptors like HIMS. This suggests the HIMS rally is driven more by speculative positioning and options activity rather than sector-wide catalysts. However, a continued HIMS breakout could signal renewed interest in the digital health space, potentially drawing attention back to the sector.

Options and ETF Picks for a High-Volatility HIMS Environment
• 200-day MA: $40.35 (far above current price; bearish)
• 30-day MA: $19.46 (bullish cross)
• RSI: 34.08 (oversold)
• MACD: -0.164 (bearish signal); Signal Line: 0.131; Histogram: -0.295
• Bollinger Bands: $27.98 (Upper), $21.34 (Middle), $14.71 (Lower)
• Implied Volatility in options chain ranges from 57.6% to 293.2%

With HIMS above its 30-day MA and RSI in oversold territory, the short-term technicals point to potential for a continuation of the rally. Aggressive bulls can leverage the options market by selecting high-gamma, high-leverage contracts with favorable strike prices and moderate deltas. Here are two top picks from the options chain:

• HIMS20260410C19 (Call Option, Strike: $19, Expiry: 2026-04-10)
– Implied Volatility: 106.28% (high)
– Delta: 0.7113 (high)
– Gamma: 0.0895 (strong sensitivity to price)
– Theta: -0.1077 (time decay; high)
– Turnover: 94,833 (high liquidity)
– LVR: 9.40%
This option is an ideal play for a continuation of the current upward move. The high gamma means it will respond sharply to further HIMS price movement, while the moderate delta ensures it’s not overly sensitive to volatility. A 5% upside to $21.81 could generate a significant return: max(0, 21.81 – 19) = $2.81.

• HIMS20260410C18.5 (Call Option, Strike: $18.5, Expiry: 2026-04-10)
– Implied Volatility: 117.97% (high)
– Delta: 0.7427 (high)
– Gamma: 0.0762 (strong sensitivity)
– Theta: -0.1112 (high decay)
– Turnover: 15,519 (high liquidity)
– LVR: 7.80%
This option is also a strong contender, with a slightly lower strike price to give more buffer for a potential pullback. A 5% move to $21.81 would yield max(0, 21.81 – 18.5) = $3.31, offering a compelling return.

For leveraged exposure, the Defiance Daily Target 2X Long HIMS ETF (HIMZ) has surged 21.8% intraday, outperforming the stock. With HIMS above its 30-day MA and options liquidity surging, this is a high-conviction short-to-medium term trade.

Backtest Hims & Hers Health Stock Performance
The backtest of HIMS's performance after a 11% intraday increase from 2022 to now shows favorable results. The 3-Day win rate is 50.79%, the 10-Day win rate is 56.35%, and the 30-Day win rate is 58.33%, indicating a higher probability of positive returns in the short term. The maximum return during the backtest was 17.08%, which occurred on day 59, suggesting that there is potential for significant gains following the intraday surge.

HIMS on the Brink – A Tactical Setup for the Bold
HIMS is now in a pivotal position as it pushes above its 30-day MA and moves closer to its 200-day MA of $40.35—a historically bearish level. The combination of oversold RSI, rising volume, and a gamma squeeze suggests the momentum could continue, but traders must remain cautious as the 52-week high remains at $70.43. Medtronic (MDT), the sector leader, is up only 0.73%, indicating HIMS’s move is largely self-contained. For aggressive traders, the HIMS20260410C19 and HIMS20260410C18.5 options offer compelling leverage. A sustained close above $21.34—Bollinger Middle Band—could signal a larger breakout is in the works. Watch for the $21.34 level to hold and for options volume to stay elevated.